Halmisson D'Arley S Siqueira1, Benedito S Neto1, Damião P Sousa2, Bruno S Gomes1, Francilene Vieira da Silva1, Francisco V M Cunha3, Carlos W S Wanderley2, Gabriel Pinheiro2, André G F Cândido2, Deysi V T Wong2, Ronaldo A Ribeiro2, Roberto C P Lima-Júnior2, Francisco A Oliveira1. 1. Medicinal Plants Research Center, Federal University of Piauí, (unnumbered), 64049-550 Teresina, Piauí, Brazil; Physiology and Pharmacology Department, Medicine Faculty, Federal University of Ceará, Cel. Nunes de Melo 1127, 60430-270 Fortaleza, CE, Brazil. 2. Pharmaceutical Sciences Department, Federal University of Paraíba, Jardim Universitário, 58051-970 João Pessoa, PB, Brazil; Physiology and Pharmacology Department, Medicine Faculty, Federal University of Ceará, Cel. Nunes de Melo 1127, 60430-270 Fortaleza, CE, Brazil. 3. Medicinal Plants Research Center, Federal University of Piauí, (unnumbered), 64049-550 Teresina, Piauí, Brazil; Physiology and Pharmacology Department, Medicine Faculty, Federal University of Ceará, Cel. Nunes de Melo 1127, 60430-270 Fortaleza, CE, Brazil. Electronic address: orfeuyeuridice@yahoo.com.br.
Abstract
AIMS: We aimed to investigate the modulating effect of α-phellandrene on neutrophil migration and mast cell degranulation processes. MAIN METHODS: Male Wistar rats or Swiss mice were treated p.o. with vehicle (3% Tween 80, p.o.), α-phellandrene (50, 100, or 200mg/kg, p.o.), or dexamethasone (0.5mg/kg, p.o.) 1h before carrageenan injection. Then, the neutrophil migration in 6-day-old air pouches or peritoneal cavities. The leukocyte rolling and adhesion were measured in real time and assessed by intravital microscopy. ELISA was used to detect TNF-α and IL-6 in peritoneal lavage. Compound 48/80-induced mast cell degranulation was assessed in mesenteric rat tissues. KEY FINDINGS: In all the tested doses, α-phellandrene prevented carrageenan-induced neutrophil accumulation (P<0.05). As detected by intravital microscopy, α-phellandrene also inhibited leukocyte rolling and adhesion, as well as significantly inhibited the production of the pro-inflammatory cytokines TNF-α and IL-6. Moreover, the degranulation of compound 48/80-induced mast cells was also inhibited by α-phellandrene (P<0.001). SIGNIFICANCE: These results suggest that α-phellandrene plays an important role as an anti-inflammatory agent through neutrophil migration modulation and mast cell stabilization.
AIMS: We aimed to investigate the modulating effect of α-phellandrene on neutrophil migration and mast cell degranulation processes. MAIN METHODS: Male Wistar rats or Swiss mice were treated p.o. with vehicle (3% Tween 80, p.o.), α-phellandrene (50, 100, or 200mg/kg, p.o.), or dexamethasone (0.5mg/kg, p.o.) 1h before carrageenan injection. Then, the neutrophil migration in 6-day-old air pouches or peritoneal cavities. The leukocyte rolling and adhesion were measured in real time and assessed by intravital microscopy. ELISA was used to detect TNF-α and IL-6 in peritoneal lavage. Compound 48/80-induced mast cell degranulation was assessed in mesenteric rat tissues. KEY FINDINGS: In all the tested doses, α-phellandrene prevented carrageenan-induced neutrophil accumulation (P<0.05). As detected by intravital microscopy, α-phellandrene also inhibited leukocyte rolling and adhesion, as well as significantly inhibited the production of the pro-inflammatory cytokines TNF-α and IL-6. Moreover, the degranulation of compound 48/80-induced mast cells was also inhibited by α-phellandrene (P<0.001). SIGNIFICANCE: These results suggest that α-phellandrene plays an important role as an anti-inflammatory agent through neutrophil migration modulation and mast cell stabilization.
Authors: Rita de Cássia da Silveira E Sá; Tamires Cardoso Lima; Flávio Rogério da Nóbrega; Anna Emmanuela Medeiros de Brito; Damião Pergentino de Sousa Journal: Int J Mol Sci Date: 2017-12-09 Impact factor: 5.923
Authors: Michele Antonelli; Davide Donelli; Grazia Barbieri; Marco Valussi; Valentina Maggini; Fabio Firenzuoli Journal: Int J Environ Res Public Health Date: 2020-09-07 Impact factor: 3.390
Authors: Elena Todirascu-Ciornea; Heba A S El-Nashar; Nada M Mostafa; Omayma A Eldahshan; Razvan Stefan Boiangiu; Gabriela Dumitru; Lucian Hritcu; Abdel Nasser B Singab Journal: Evid Based Complement Alternat Med Date: 2019-12-02 Impact factor: 2.629